Home/Filings/4/0001209191-15-078372
4//SEC Filing

INSITE VISION INC 4

Accession 0001209191-15-078372

CIK 0000802724operating

Filed

Nov 3, 7:00 PM ET

Accepted

Nov 4, 3:55 PM ET

Size

21.8 KB

Accession

0001209191-15-078372

Insider Transaction Report

Form 4
Period: 2015-11-02
Hosseini Kamran
VP, Clinical Affairs & CMO
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2015-11-0240,0000 total
    Exercise: $0.60From: 2009-03-24Exp: 2018-03-24Common Stock (40,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2015-11-02$0.35/sh300,000$105,0000 total
    Exercise: $0.20From: 2010-02-17Exp: 2019-02-17Common Stock (300,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2015-11-02250,0000 total
    Exercise: $0.50From: 2013-01-27Exp: 2022-01-27Common Stock (250,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2015-11-02$0.35/sh325,000$113,7500 total
    Exercise: $0.29From: 2015-01-07Exp: 2024-01-07Common Stock (325,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2015-11-02300,0000 total
    Exercise: $0.42From: 2011-04-01Exp: 2020-04-01Common Stock (300,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2015-11-02$0.35/sh325,000$113,7500 total
    Exercise: $0.32From: 2014-01-24Exp: 2023-01-24Common Stock (325,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2015-11-02$0.35/sh325,000$113,7500 total
    Exercise: $0.21From: 2016-01-28Exp: 2025-01-28Common Stock (325,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2015-11-02250,0000 total
    Exercise: $0.36From: 2012-01-21Exp: 2021-01-21Common Stock (250,000 underlying)
Footnotes (3)
  • [F1]The option is scheduled to vest as to 25% of the shares covered by the option on the first anniversary of the grant date and as to the remaining 75% of the shares on a daily basis over the three-year period thereafter.
  • [F2]In accordance with the terms of the Agreement and Plan of Merger, dated September 15, 2015, as amended and restated, by and among Thea Acquisition Corp ("Purchaser"), Ranbaxy, Inc. and InSite Vision Incorporated ("Issuer") pursuant to which Purchaser was merged with and into Issuer (the "Merger"), this stock option was cancelled at the effective time of the Merger without consideration because the exercise price of the stock option equaled or exceeded $0.35 per share.
  • [F3]This option was cancelled in connection with the Merger in exchange for a cash payment per share equal to the difference between $0.35 and the exercise price of the option.

Issuer

INSITE VISION INC

CIK 0000802724

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000802724

Filing Metadata

Form type
4
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 3:55 PM ET
Size
21.8 KB